Treatment with N-acetylcysteine does not alter blood glucose levels and the oxidative stress status in diabetic rats

Journal of Pharmaceutical Negative Results

Volumn 4, Issue 1, 2013, Pages 5-12

  De Bairros, André ^a,b   Roehrs, Miguel ^b   Ribeiro, Gianine ^b   De Freitas, Fernando ^b   Moreira, Ana ^b   Tonello, Raquel ^b   Mazzanti, Cinthia ^b   Leal, Mirna ^b   Morsch, Vera ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Blood; butyrylcholinesterase; diabetes; N acetylcysteine; oxidative stress; rats

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALLOXAN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CATALASE; CHOLINESTERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HEMOGLOBIN A1C; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UREA;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETOGENESIS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; RAT;

EID: 84883673803     PISSN: 09769234     EISSN: 22297723     Source Type: Journal    
DOI: 10.4103/0976-9234.116755     Document Type: Article

References (45)

1. Halliwell B, Gutteridge JC. Free radicals and antioxidants in the year 2000. Ann N Y Acad Sci 2000;899:136-47.
2. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006;212:167-78.
3. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetics complications. Sultan Qaboos Univ Med J 2012;12:5-18.
4. Federico A, Trappoliere M, Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives. Dig Liver Dis 2006;38:789-01.
5. West J, Brousil J, Gazis A, Jackson L, Mansell P, Bennett A, et al. Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. Q J Med 2006;99:871-6. (Pubitemid 46024098)
6. Al-Shamsi M, Amin A, Adeghate E. Vitamin E ameliorates some biochemical parameters in normal and diabetic rats. Ann N Y Acad Sci 2006;1084:411-31. (Pubitemid 47091966)
7. Dave KR, Katyare SS. Effect of alloxan-induced diabetes on serum and cardiac butyrylcholinesterase in the rat. J Endocrinol 2002;175:241-50. (Pubitemid 35276603)
8. Abbott CA, Mackness MI, Kumar S, Olukoga AO, Gordon C, Arrol S, et al. Relationship between butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clin Sci 1993;85:77-81. (Pubitemid 23214381)
9. Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003;4:131-8. (Pubitemid 37271383)
10. Guo Z, Xia Z, Jiang J, McNeill J. Downregulation of NADPH oxidase, antioxidant enzymes and inflammatory markers in the heart of streptozotocin-induced diabetics rats by N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol 2007;292:H1728-36. (Pubitemid 46572395)
11. Kaneto H, Kajimoto Y, Miyagawa JI, Matsuoka TA, Fujitani Y, Yutaka U, et al. Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic b-cells against glucose toxicity. Diabetes 1999;48:2398-06.
12. Maritim AC, Sandres RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: A Review. J Biochem Mol Toxicol 2003;17:24-38. (Pubitemid 36410972)
13. Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, Cosso L, et al. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 2003;2:499-05.
14. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-7. (Pubitemid 19147809)
15. Coyle LC, Rodriguez A, Jeschke RE, Simon-Lee A, Abbott KC, Taylor AJ. Acetylcysteine in Diabetes (AID): A randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am Heart J 2006;151:1032.e9-12.
16. Millea PJ. N-acetylcysteine: Multiple clinical applications. Am Fam Physician 2009;80:265-9.
17. Trimarchi H, Mongitore MR, Baglioni P, Forrester B, Freixas M, Schropp M, et al. N-Acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients-a pilot study. Clin Nephrol 2003;59:441-6. (Pubitemid 36722325)
18. Lazárová M, Stejskal D, Lacnac B, Václavik J, Adamovská S, Ochmanová R, et al. The antioxidant acetylcysteine reduces oxidative stress by decreasing level of AOPPs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:131-3.
19. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008;51:216-26.
20. Ribeiro G, Roehrs M, Bairros A, Moro A, Charão M, Araújo F, et al. N-acetylcysteine on oxidative damage in diabetic rats. Drug Chem Toxicol 2011;34:467-74.
21. Ellman GL, Courtney KD, Andres VJr, Feather-Stone RM. A new and rapide colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
22. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
23. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
24. Wendel A. Glutathione peroxidase. Methods Enzymol 1981;77:325-33.
25. Garcia SC, Schott KL, Charão MF, Moro AM, Bulcão R, Grotto D, et al. Quantification of reduced glutathione by HPLC-UV in erythrocytes haemodialysis patients. Biomed Chromatogr 2008;22:460-8. (Pubitemid 351727820)
26. Grotto D, Santa Maria LD, Boeira S, Valentini J, Charão MF, Moro AM, et al. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography- visible detection. J Pharm Biomed Anal 2006;43:619-24.
27. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 1969;244:6056-63.
28. Darmaun D, Smith SD, Sweeten S, Hartman BK, Welch S, Mauras N. Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: Apparent resistence to N-acetylcysteine supplementation. Pediatr Diab 2008;9;577-82.
29. Capellini VK, Baldo CF, Celotto AC, Batalhão ME, Cárnio EC, Rodrigues AJ, et al. Oxidative stress is not associated with vascular dysfunction in a model of alloxan-induced diabetic rats. Arq Bras Endocrinol Metabol 2010;54:530-9.
30. Sakurai K, Miura T. Generation of free radicals by alloxan in the presence of bovine serum albumin: A role of protein sulfhydryl groups in alloxan cytotoxicity. Biochem Int 1989;19:405-12. (Pubitemid 19216497)
31. Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006;40:1339-49. (Pubitemid 44698283)
32. Masha A, Brocato L, Dinatale S, Mascia C, Biasi F, Martina V. N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus. J Endocrinol Invest 2009;32:352-6.
33. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients. Diagn Pathol 2007;2:22.
34. Silva M, Lima WG, Silva ME, Pedrosa ML. Effect of streptozotocin on the glycemic and lipid profiles and oxidative stress in hamsters. Arquivos Brasileiros de Endocrinologia and Metabologia 2011;55:46-53.
35. Kamboj SS, Vasishta RK, Sandhir R. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 2010;112:77-91.
36. Winterbourn CC, Metodiewa D. Reactivity of biologically important compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 1999;27:322-8. (Pubitemid 29395424)
37. Hwang I, Lee J, Huh JY, Park J, Lee HB, Ho YS, et al. Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 2012;61:728-38.
38. Urata Y, Yamamoto H, Goto S, Tsushima H, Akazawa S, Yamashita S, et al. Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-Ibeta and tumor necrosis factor-alpha in mouse endothelial cells. J Biol Chem 1996;271:15146-52. (Pubitemid 26194994)
39. Patriarca S, Furfaro AL, Domenicotti C, Odetti P, Cottalasso D, Marinari UM, et al. Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress. Biochim Biophys Acta 2005;1741:48-54. (Pubitemid 40824989)
40. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 2004;37:959-68. (Pubitemid 39446821)
41. De Caro L, Ghizzi A, Costa R, Longo A, Ventresca GP, Lodola E. Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers. Drug Research 1989;39:382-5.
42. Johnson RM, Goyette G Jr, Ravindranath Y, Ho YS. Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med 2005;39:1407-17. (Pubitemid 41547221)
43. Mills BJ, Lang CA. Differential distribution of free and bound glutathione and cyst(e)ine in human blood. Biochem Pharmacol 1996;52:401-6. (Pubitemid 26233582)
44. Das UN. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit 2007;13:RA214-21. (Pubitemid 350272890)
45. Csontos C, Rezman B, Foldi V, Bogar L, Drenkovics L, Röth E, et al. Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn. Burns 2011;38:428-37.